Scientists have discovered an antibody treatment that may help prevent both muscle loss and bone density loss in people using ...

Although the first GLP-1 drug was approved by the US Food and Drug Administration (FDA) in the early 2000s, it wasn't until a ...

Weight-loss medication has taken the world by storm and helped many overweight people. But for some, significant weight loss ...

The high prevalence of sarcopenia in patients with ovarian and endometrial cancers underscores the importance of early ...

Weight-loss drugs have helped many people lose excess weight, but for some, rapid weight loss comes with a hidden risk—the ...

“These findings have the potential to direct therapeutic strategies aimed at preserving muscle mass to afford healthy aging and combat muscle-wasting diseases such as sarcopenia and cachexia ...

Even 12% of subjects present together all the nutritional deficiencies studied. All patients with sarcopenia had at least one of the other deficiencies. The results of this study, obtained from a ...

Weight loss medication has taken the world by storm and helped many overweight people. But for some, significant weight loss ...

US Patent US 12,109,192 B covers the two preferred crystalline forms of S-pindolol benzoate. Actimed Therapeutics is a clinical stage speciality pharmaceutical company focused on bringing innovation ...

The work is published in the Journal of Cachexia, Sarcopenia and Muscle. "We are the first to study how certain drugs affect bones, and the results show that bimagrumab can increase the amount of ...